Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies
Conventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/10/1613 |
_version_ | 1797513394364874752 |
---|---|
author | Jiaxiang Zhang Anqi Lu Rishi Thakkar Yu Zhang Mohammed Maniruzzaman |
author_facet | Jiaxiang Zhang Anqi Lu Rishi Thakkar Yu Zhang Mohammed Maniruzzaman |
author_sort | Jiaxiang Zhang |
collection | DOAJ |
description | Conventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main objective of the current investigation is to develop oral thin film (OTF) formulations using novel solvent-free approaches, including additive manufacturing (AM), hot-melt extrusion, and melt casting. AM, popularly recognized as 3D printing, has been widely utilized for on-demand and personalized formulation development in the pharmaceutical industry. Additionally, in general active pharmaceutical ingredients (APIs) are dissolved or dispersed in polymeric matrices to form amorphous solid dispersions (ASDs). In this study, acetaminophen (APAP) was selected as the model drug, and Klucel™ hydroxypropyl cellulose (HPC) E5 and Soluplus<sup>®</sup> were used as carrier matrices to form the OTFs. Amorphous OTFs were successfully manufactured by hot-melt extrusion and 3D printing technologies followed by comprehensive studies on the physico-chemical properties of the drug and developed OTFs. Advanced physico-chemical characterizations revealed the presence of amorphous drug in both HME and 3D printed films whereas some crystalline traces were visible in solvent and melt cast films. Moreover, advanced surface analysis conducted by Raman mapping confirmed a more homogenous distribution of amorphous drugs in 3D printed films compared to those prepared by other methods. A series of mathematical models were also used to describe drug release mechanisms from the developed OTFs. Moreover, the in vitro dissolution studies of the 3D printed films demonstrated an improved drug release performance compared to the melt cast or extruded films. This study suggested that HME combined with 3D printing can potentially improve the physical properties of formulations and produce OTFs with preferred qualities such as faster dissolution rate of drugs. |
first_indexed | 2024-03-10T06:15:58Z |
format | Article |
id | doaj.art-1b78c12d35034531a6dbf644e1a5a760 |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-10T06:15:58Z |
publishDate | 2021-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-1b78c12d35034531a6dbf644e1a5a7602023-11-22T19:38:31ZengMDPI AGPharmaceutics1999-49232021-10-011310161310.3390/pharmaceutics13101613Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion TechnologiesJiaxiang Zhang0Anqi Lu1Rishi Thakkar2Yu Zhang3Mohammed Maniruzzaman4Pharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAPharmaceutical Engineering and 3D Printing (PharmE3D) Laboratory, Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USAConventional oral dosage forms may not always be optimal especially for those patients suffering from dysphasia or difficulty swallowing. Development of suitable oral thin films (OTFs), therefore, can be an excellent alternative to conventional dosage forms for these patient groups. Hence, the main objective of the current investigation is to develop oral thin film (OTF) formulations using novel solvent-free approaches, including additive manufacturing (AM), hot-melt extrusion, and melt casting. AM, popularly recognized as 3D printing, has been widely utilized for on-demand and personalized formulation development in the pharmaceutical industry. Additionally, in general active pharmaceutical ingredients (APIs) are dissolved or dispersed in polymeric matrices to form amorphous solid dispersions (ASDs). In this study, acetaminophen (APAP) was selected as the model drug, and Klucel™ hydroxypropyl cellulose (HPC) E5 and Soluplus<sup>®</sup> were used as carrier matrices to form the OTFs. Amorphous OTFs were successfully manufactured by hot-melt extrusion and 3D printing technologies followed by comprehensive studies on the physico-chemical properties of the drug and developed OTFs. Advanced physico-chemical characterizations revealed the presence of amorphous drug in both HME and 3D printed films whereas some crystalline traces were visible in solvent and melt cast films. Moreover, advanced surface analysis conducted by Raman mapping confirmed a more homogenous distribution of amorphous drugs in 3D printed films compared to those prepared by other methods. A series of mathematical models were also used to describe drug release mechanisms from the developed OTFs. Moreover, the in vitro dissolution studies of the 3D printed films demonstrated an improved drug release performance compared to the melt cast or extruded films. This study suggested that HME combined with 3D printing can potentially improve the physical properties of formulations and produce OTFs with preferred qualities such as faster dissolution rate of drugs.https://www.mdpi.com/1999-4923/13/10/1613additive manufacturingamorphous solid dispersionoral thin filmhot-melt extrusiondissolution kinetics |
spellingShingle | Jiaxiang Zhang Anqi Lu Rishi Thakkar Yu Zhang Mohammed Maniruzzaman Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies Pharmaceutics additive manufacturing amorphous solid dispersion oral thin film hot-melt extrusion dissolution kinetics |
title | Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies |
title_full | Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies |
title_fullStr | Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies |
title_full_unstemmed | Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies |
title_short | Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies |
title_sort | development and evaluation of amorphous oral thin films using solvent free processes comparison between 3d printing and hot melt extrusion technologies |
topic | additive manufacturing amorphous solid dispersion oral thin film hot-melt extrusion dissolution kinetics |
url | https://www.mdpi.com/1999-4923/13/10/1613 |
work_keys_str_mv | AT jiaxiangzhang developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies AT anqilu developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies AT rishithakkar developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies AT yuzhang developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies AT mohammedmaniruzzaman developmentandevaluationofamorphousoralthinfilmsusingsolventfreeprocessescomparisonbetween3dprintingandhotmeltextrusiontechnologies |